Very high compliance in an expanded MS-MS-based newborn screening program despite written parental consent

Bernhard Liebl1, Uta Nennstiel-Ratzel, Rüdiger von Kries

  • 1Public Health Newborn Screening Center of the State of Bavaria, Landesuntersuchungsamt Südbayern, D-85762 Oberschleissheim, Germany. bernhard.liebl@t-online.de

Preventive Medicine
|January 31, 2002
PubMed

Insights

Implementing written parental consent for expanded newborn screening in Bavaria achieved high compliance. Systematic tracking and clear information ensured successful participation in the mass spectrometry-based program.

Area of Science:

  • Medical Genetics
  • Public Health
  • Biochemistry

Background:

  • Expanded newborn screening using mass spectrometry (MS-MS) was introduced in Bavaria in 1999.
  • The program's novelty and expanded scope necessitated a written parental consent procedure.

Purpose of the Study:

  • To evaluate the impact of a written consent procedure on compliance rates in a newborn screening program.
  • To assess demographic factors influencing participation in newborn screening with consent.

Main Methods:

  • A systematic demographic tracking system was employed to monitor screening participation.
  • Screening notifications were cross-referenced with birth records.
  • Parents of non-screened infants were contacted for counseling.

Main Results:

  • Over 123,000 infants were eligible; 116,652 were successfully matched.
  • Screening refusal by parents was low, affecting only 0.1% of the target population.
  • High compliance was achieved despite the consent requirement, with most initial non-responders eventually participating or being tested later.

Conclusions:

  • Written parental consent for newborn screening is feasible.
  • Effective information dissemination and robust tracking systems are crucial for maintaining high compliance rates.
  • MS-MS-based newborn screening programs can successfully implement consent procedures.
Abstract

Related Concept Videos